Arcellx IncNASDAQ:ACLX
- LAST PRICE53.2500
- TODAY'S CHANGE (%)-0.3500 (-0.6530%)
- Bid / Lots47.6900/ 1
- Ask / Lots56.1300/ 1
- Open / Previous Close53.0800 / 53.6000
- Day Range
- 52 Week Range
- Volume541,417
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACLX |
|---|---|---|
| 09:32 ET | 3515 | 53.29 |
| 09:34 ET | 929 | 53.44 |
| 09:36 ET | 650 | 53.37 |
| 09:38 ET | 1300 | 53.5059 |
| 09:41 ET | 400 | 53.87 |
| 09:43 ET | 1667 | 53.73 |
| 09:45 ET | 2700 | 53.76 |
| 09:48 ET | 200 | 53.96 |
| 09:50 ET | 200 | 53.93 |
| 09:52 ET | 900 | 53.81 |
| 09:54 ET | 1774 | 53.7 |
| 09:56 ET | 500 | 53.61 |
| 09:57 ET | 2165 | 53.625 |
| 09:59 ET | 1950 | 53.75 |
| 10:01 ET | 700 | 53.785 |
| 10:03 ET | 100 | 53.7 |
| 10:08 ET | 1852 | 53.555 |
| 10:12 ET | 648 | 53.45 |
| 10:15 ET | 1199 | 53.46 |
| 10:17 ET | 400 | 53.46 |
| 10:19 ET | 600 | 53.55 |
| 10:30 ET | 100 | 53.46 |
| 10:32 ET | 300 | 53.5 |
| 10:33 ET | 1595 | 53.385 |
| 10:35 ET | 1500 | 53.48 |
| 10:37 ET | 100 | 53.505 |
| 10:42 ET | 981 | 53.495 |
| 10:44 ET | 3487 | 53.16 |
| 10:46 ET | 2248 | 53.075 |
| 10:48 ET | 999 | 53.195 |
| 10:50 ET | 500 | 53.41 |
| 10:51 ET | 500 | 53.45 |
| 10:53 ET | 100 | 53.45 |
| 10:57 ET | 100 | 53.37 |
| 11:00 ET | 100 | 53.41 |
| 11:04 ET | 250 | 53.455 |
| 11:06 ET | 924 | 53.45 |
| 11:08 ET | 400 | 53.29 |
| 11:09 ET | 1000 | 53.45 |
| 11:11 ET | 300 | 53.585 |
| 11:13 ET | 599 | 53.52 |
| 11:15 ET | 100 | 53.505 |
| 11:22 ET | 100 | 53.59 |
| 11:26 ET | 400 | 53.59 |
| 11:27 ET | 648 | 53.59 |
| 11:29 ET | 100 | 53.66 |
| 11:31 ET | 350 | 53.745 |
| 11:33 ET | 1013 | 53.68 |
| 11:36 ET | 1000 | 53.62 |
| 11:38 ET | 1518 | 53.44 |
| 11:40 ET | 600 | 53.59 |
| 11:42 ET | 1690 | 53.64 |
| 11:44 ET | 23462 | 53.54 |
| 11:45 ET | 1065 | 53.63 |
| 11:47 ET | 200 | 53.58 |
| 11:49 ET | 1000 | 53.45 |
| 11:51 ET | 400 | 53.56 |
| 11:54 ET | 1200 | 53.635 |
| 11:56 ET | 800 | 53.73 |
| 11:58 ET | 200 | 53.715 |
| 12:00 ET | 700 | 53.85 |
| 12:02 ET | 3299 | 53.49 |
| 12:03 ET | 200 | 53.54 |
| 12:05 ET | 400 | 53.59 |
| 12:07 ET | 200 | 53.71 |
| 12:09 ET | 200 | 53.68 |
| 12:14 ET | 2769 | 53.82 |
| 12:16 ET | 1999 | 53.64 |
| 12:18 ET | 300 | 53.71 |
| 12:20 ET | 1346 | 53.71 |
| 12:21 ET | 2751 | 53.89 |
| 12:23 ET | 2164 | 53.815 |
| 12:25 ET | 200 | 53.8 |
| 12:27 ET | 1050 | 53.87 |
| 12:30 ET | 350 | 53.87 |
| 12:32 ET | 100 | 53.899 |
| 12:34 ET | 1696 | 53.735 |
| 12:36 ET | 2012 | 53.875 |
| 12:38 ET | 300 | 53.83 |
| 12:39 ET | 1100 | 53.805 |
| 12:41 ET | 200 | 53.8 |
| 12:43 ET | 200 | 53.76 |
| 12:45 ET | 200 | 53.75 |
| 12:48 ET | 3842 | 53.7 |
| 12:50 ET | 3250 | 53.65 |
| 12:52 ET | 722 | 53.66 |
| 12:54 ET | 900 | 53.665 |
| 12:56 ET | 300 | 53.675 |
| 12:57 ET | 1869 | 53.62 |
| 12:59 ET | 12983 | 53.4 |
| 01:01 ET | 12120 | 53.3725 |
| 01:03 ET | 5520 | 53.23 |
| 01:06 ET | 1300 | 53.37 |
| 01:08 ET | 1450 | 53.42 |
| 01:10 ET | 2815 | 53.535 |
| 01:12 ET | 1350 | 53.65 |
| 01:14 ET | 300 | 53.6 |
| 01:15 ET | 100 | 53.705 |
| 01:17 ET | 1550 | 53.54 |
| 01:19 ET | 400 | 53.55 |
| 01:21 ET | 1091 | 53.5 |
| 01:24 ET | 400 | 53.485 |
| 01:26 ET | 200 | 53.45 |
| 01:28 ET | 1650 | 53.39 |
| 01:30 ET | 700 | 53.395 |
| 01:32 ET | 802 | 53.38 |
| 01:33 ET | 600 | 53.35 |
| 01:35 ET | 478 | 53.36 |
| 01:37 ET | 1996 | 53.5 |
| 01:39 ET | 900 | 53.61 |
| 01:42 ET | 1505 | 53.45 |
| 01:44 ET | 200 | 53.32 |
| 01:46 ET | 300 | 53.29 |
| 01:48 ET | 1150 | 53.33 |
| 01:50 ET | 678 | 53.315 |
| 01:51 ET | 685 | 53.28 |
| 01:53 ET | 100 | 53.29 |
| 01:55 ET | 750 | 53.29 |
| 01:57 ET | 519 | 53.205 |
| 02:00 ET | 800 | 53.18 |
| 02:02 ET | 1178 | 53.105 |
| 02:06 ET | 200 | 53.03 |
| 02:08 ET | 1500 | 53.145 |
| 02:11 ET | 1100 | 53.29 |
| 02:13 ET | 1550 | 53.26 |
| 02:15 ET | 300 | 53.18 |
| 02:18 ET | 478 | 53.215 |
| 02:20 ET | 350 | 53.21 |
| 02:22 ET | 100 | 53.21 |
| 02:24 ET | 920 | 53.205 |
| 02:29 ET | 1685 | 53.3 |
| 02:31 ET | 100 | 53.3 |
| 02:33 ET | 200 | 53.27 |
| 02:36 ET | 600 | 53.32 |
| 02:38 ET | 600 | 53.36 |
| 02:40 ET | 1100 | 53.38 |
| 02:42 ET | 2003 | 53.3 |
| 02:45 ET | 200 | 53.27 |
| 02:47 ET | 500 | 53.23 |
| 02:49 ET | 650 | 53.22 |
| 02:51 ET | 600 | 53.185 |
| 02:54 ET | 929 | 53.17 |
| 02:56 ET | 400 | 53.19 |
| 02:58 ET | 1033 | 53.23 |
| 03:00 ET | 450 | 53.2425 |
| 03:02 ET | 1550 | 53.26 |
| 03:03 ET | 625 | 53.21 |
| 03:05 ET | 262 | 53.215 |
| 03:09 ET | 1000 | 53.23 |
| 03:12 ET | 1450 | 53.205 |
| 03:14 ET | 1300 | 53.25 |
| 03:16 ET | 100 | 53.265 |
| 03:18 ET | 1000 | 53.33 |
| 03:20 ET | 100 | 53.28 |
| 03:21 ET | 25400 | 53.165 |
| 03:23 ET | 1055 | 53.16 |
| 03:25 ET | 3800 | 53.24 |
| 03:27 ET | 1023 | 53.25 |
| 03:30 ET | 300 | 53.245 |
| 03:32 ET | 1419 | 53.29 |
| 03:34 ET | 1334 | 53.2765 |
| 03:36 ET | 226 | 53.26 |
| 03:38 ET | 1700 | 53.25 |
| 03:39 ET | 2009 | 53.25 |
| 03:41 ET | 400 | 53.255 |
| 03:43 ET | 851 | 53.21 |
| 03:45 ET | 1700 | 53.23 |
| 03:48 ET | 2450 | 53.175 |
| 03:50 ET | 4952 | 53.09 |
| 03:52 ET | 4361 | 53.24 |
| 03:54 ET | 1257 | 53.19 |
| 03:56 ET | 11661 | 53.25 |
| 03:57 ET | 9266 | 53.3 |
| 03:59 ET | 10880 | 53.25 |
Jun 18, 2024
DJ Arcellx Is Maintained at Buy by Truist Securities, from 1:58PM ET on Tuesday Jun 18, 2024 by Dow Jones
1:58PM ET on Tuesday Jun 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcellx Inc | 2.9B | -51.3x | --- |
Rhythm Pharmaceuticals Inc | 2.6B | -9.2x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.2x | --- |
IDEAYA Biosciences Inc | 2.7B | -16.9x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.5x | --- |
TG Therapeutics Inc | 2.8B | 83.0x | --- |
Company Information
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Contact Information
- Headquarters
- 800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 240-327-0603
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rami Elghandour
- Chief Financial Officer
- Michelle Gilson
- Chief Medical Officer
- Christopher Heery
- Independent Director
- Ali Behbahani
- Independent Director
- Jill Carroll
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $131.7M |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.04 |
Book Value | $9.28 |
P/E Ratio | -51.3x |
Price/Sales (TTM) | 21.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
